Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 8,309 shares of the stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $15.45, for a total transaction of $128,374.05. Following the transaction, the vice president directly owned 61,968 shares in the company, valued at approximately $957,405.60. This represents a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Arteris Stock Up 8.3%
Arteris stock opened at $17.58 on Wednesday. The company has a market capitalization of $767.89 million, a PE ratio of -21.18 and a beta of 1.48. The firm has a fifty day simple moving average of $15.20 and a two-hundred day simple moving average of $12.01. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $19.85.
Arteris (NASDAQ:AIP – Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.02. The company had revenue of $17.41 million for the quarter, compared to the consensus estimate of $17.00 million. As a group, equities analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
AIP has been the subject of a number of analyst reports. Wall Street Zen raised Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Cowen reiterated a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Rosenblatt Securities restated a “buy” rating and issued a $20.00 price objective on shares of Arteris in a research report on Monday, December 15th. Finally, TD Cowen upped their price objective on shares of Arteris from $15.00 to $16.50 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Arteris has an average rating of “Moderate Buy” and a consensus target price of $17.50.
Read Our Latest Report on Arteris
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Arteris
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
